ENTA logo

Enanta Pharmaceuticals (ENTA) Selling, General & Administrative Expenses

Annual SGA

$57.85 M
+$4.96 M+9.38%

September 30, 2024

Summary

Performance

1-Year Change

+9.38%

3-Year Change

+77.8%

5-Year Change

+120.41%

15-Year Change

+178.81%

ENTA SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

64.34%
ENTA annual SGA is higher than 64.34% of companies in Healthcare sector

High & Low

All-time High

$57.85 M
ENTA annual SGA is currently at an all-time high

3-Year Low

$32.54 M
ENTA annual SGA is currently +77.80% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
ENTA previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
ENTA next annual earnings announcement has not yet been scheduled

OtherENTAexpensesmetrics:

Annual Total Expenses

$189.33 M
ENTA annual total expenses is $189.33 million

Annual Operating Expenses

$189.33 M
ENTA annual total operating expenses is $189.33 million

Annual Cost Of Goods Sold

-
ENTA annual cost of goods sold value is unknown

Annual Interest Expense

$10.94 M
ENTA annual interest expense is $10.94 million

Quarterly SGA

$13.68 M
+$269.00 K+2.01%

September 30, 2024

Summary

Performance

3-Month Change

+2.01%

1-Year Change

-0.81%

3-Year Change

+63.75%

5-Year Change

+63.75%

ENTA Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.06%
ENTA quarterly SGA is higher than 61.06% of companies in Healthcare sector

High & Low

All-time High

$16.52 M
ENTA quarterly SGA is currently -17.16% below its historical high of $16.52 million

3-Year Low

$9.51 M
ENTA quarterly SGA is currently +43.91% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ENTA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
ENTA next earnings announcement is scheduled for Feb 7, 2025

OtherENTAexpensesmetrics:

Quarterly Total Expenses

$44.46 M
ENTA quarterly total expenses is $44.46 million

Quarterly Operating Expenses

$44.46 M
ENTA quarterly total operating expenses is $44.46 million

Quarterly Cost Of Goods Sold

-
ENTA quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$2.58 M
ENTA quarterly interest expense is $2.58 million

TTM SGA

-$1.13 B
-$116.05 M-11.45%

September 30, 2024

Summary

Performance

3-Month Change

-2048.2%

1-Year Change

-2235.15%

3-Year Change

-3570.67%

5-Year Change

-3570.67%

ENTA TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.91%
ENTA TTM SGA is higher than 40.91% of companies in Healthcare sector

High & Low

All-time High

$669.01 M
ENTA TTM SGA is currently -268.79% below its historical high of $669.01 million

3-Year Low

-$1.13 B
ENTA TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ENTA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
ENTA next earnings announcement is scheduled for Feb 7, 2025

OtherENTAexpensesmetrics:

Annual Total Expenses

$189.33 M
ENTA annual total expenses is $189.33 million

Annual Operating Expenses

$189.33 M
ENTA annual total operating expenses is $189.33 million

TTM Cost Of Goods Sold

-
ENTA TTM cost of goods sold value is unknown

TTM Interest Expense

$10.94 M
ENTA TTM interest expense is $10.94 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$57.85 M
ENTA annual SGA is $57.85 million

Annual Operating Expenses

$189.33 M
ENTA annual total operating expenses is $189.33 million

Annual Cost Of Goods Sold

-
ENTA annual cost of goods sold value is unknown

ENTA Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.4%-0.8%-2235.2%
3 y3 years+77.8%+63.8%-3570.7%
5 y5 years+120.4%+63.8%-3570.7%

ENTA Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+77.8%-17.2%+43.9%-575.6%at low
5 y5-yearat high+120.4%-17.2%+103.4%-268.8%at low
alltimeall timeat high+1048.7%-17.2%+1095.0%-268.8%at low

Enanta Pharmaceuticals Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
$57.85 M(+9.4%)
$13.68 M(+2.0%)
$57.85 M(-0.2%)
Jun 2024
-
$13.41 M(-5.8%)
$57.96 M(+1.4%)
Mar 2024
-
$14.23 M(-13.8%)
$57.17 M(+0.8%)
Dec 2023
-
$16.52 M(+19.7%)
$56.71 M(+7.2%)
Sep 2023
$52.89 M(+16.3%)
$13.79 M(+9.3%)
$52.89 M(+2.4%)
Jun 2023
-
$12.62 M(-8.4%)
$51.66 M(-0.6%)
Mar 2023
-
$13.78 M(+8.5%)
$51.97 M(+6.8%)
Dec 2022
-
$12.70 M(+1.0%)
$48.67 M(+7.0%)
Sep 2022
$45.48 M(+39.8%)
$12.57 M(-2.8%)
$45.48 M(+10.2%)
Jun 2022
-
$12.93 M(+23.4%)
$41.27 M(+12.1%)
Mar 2022
-
$10.48 M(+10.2%)
$36.82 M(+6.2%)
Dec 2021
-
$9.51 M(+13.8%)
$34.67 M(+6.5%)
Sep 2021
$32.54 M(+18.9%)
$8.36 M(-1.4%)
$32.54 M(+5.3%)
Jun 2021
-
$8.48 M(+1.8%)
$30.91 M(+5.7%)
Mar 2021
-
$8.33 M(+12.9%)
$29.25 M(+5.2%)
Dec 2020
-
$7.38 M(+9.6%)
$27.81 M(+1.7%)
Sep 2020
$27.36 M(+4.2%)
$6.73 M(-1.4%)
$27.36 M(+2.1%)
Jun 2020
-
$6.82 M(-0.9%)
$26.79 M(+2.6%)
Mar 2020
-
$6.88 M(-0.5%)
$26.12 M(+0.4%)
Dec 2019
-
$6.92 M(+12.3%)
$26.02 M(-0.9%)
Sep 2019
$26.25 M(+12.0%)
$6.16 M(+0.2%)
$26.25 M(+1.3%)
Jun 2019
-
$6.15 M(-9.3%)
$25.91 M(+0.1%)
Mar 2019
-
$6.78 M(-5.2%)
$25.90 M(+4.3%)
Dec 2018
-
$7.15 M(+22.7%)
$24.82 M(+5.9%)
Sep 2018
$23.44 M
$5.83 M(-5.0%)
$23.44 M(+3.1%)
Jun 2018
-
$6.13 M(+7.5%)
$22.73 M(+4.1%)
Mar 2018
-
$5.71 M(-1.1%)
$21.83 M(+1.1%)
DateAnnualQuarterlyTTM
Dec 2017
-
$5.77 M(+12.7%)
$21.58 M(+4.0%)
Sep 2017
$20.75 M(+22.3%)
$5.12 M(-2.2%)
$20.75 M(+3.4%)
Jun 2017
-
$5.23 M(-4.2%)
$20.07 M(+5.0%)
Mar 2017
-
$5.46 M(+10.6%)
$19.12 M(+5.7%)
Dec 2016
-
$4.94 M(+11.2%)
$18.09 M(+6.6%)
Sep 2016
$16.97 M(+25.3%)
$4.44 M(+3.7%)
$16.97 M(+4.6%)
Jun 2016
-
$4.28 M(-3.3%)
$16.22 M(+4.1%)
Mar 2016
-
$4.43 M(+15.9%)
$15.58 M(+6.8%)
Dec 2015
-
$3.82 M(+3.4%)
$14.59 M(+7.7%)
Sep 2015
$13.54 M(+35.2%)
$3.69 M(+1.4%)
$13.54 M(+7.4%)
Jun 2015
-
$3.64 M(+6.0%)
$12.61 M(+9.0%)
Mar 2015
-
$3.44 M(+24.2%)
$11.57 M(+8.2%)
Dec 2014
-
$2.77 M(+0.3%)
$10.70 M(+6.8%)
Sep 2014
$10.02 M(+62.0%)
$2.76 M(+6.1%)
$10.02 M(+11.2%)
Jun 2014
-
$2.60 M(+1.5%)
$9.01 M(+10.0%)
Mar 2014
-
$2.56 M(+22.9%)
$8.19 M(+15.1%)
Dec 2013
-
$2.09 M(+19.3%)
$7.12 M(+15.1%)
Sep 2013
$6.18 M(+16.6%)
$1.75 M(-2.1%)
$6.18 M(+0.8%)
Jun 2013
-
$1.79 M(+19.8%)
$6.13 M(+11.7%)
Mar 2013
-
$1.49 M(+29.6%)
$5.49 M(+5.5%)
Dec 2012
-
$1.15 M(-32.2%)
$5.20 M(-1.9%)
Sep 2012
$5.30 M(+5.3%)
$1.70 M(+48.4%)
$5.30 M(+10.3%)
Jun 2012
-
$1.15 M(-5.1%)
$4.80 M(+31.3%)
Mar 2012
-
$1.21 M(-3.5%)
$3.66 M(+49.2%)
Dec 2011
-
$1.25 M(+4.1%)
$2.45 M(+104.1%)
Sep 2011
$5.04 M(-17.5%)
$1.20 M
$1.20 M
Sep 2010
$6.11 M
-
-

FAQ

  • What is Enanta Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals annual SGA year-on-year change?
  • What is Enanta Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals quarterly SGA year-on-year change?
  • What is Enanta Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals TTM SGA year-on-year change?

What is Enanta Pharmaceuticals annual SGA?

The current annual SGA of ENTA is $57.85 M

What is the all time high annual SGA for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high annual SGA is $57.85 M

What is Enanta Pharmaceuticals annual SGA year-on-year change?

Over the past year, ENTA annual SGA has changed by +$4.96 M (+9.38%)

What is Enanta Pharmaceuticals quarterly SGA?

The current quarterly SGA of ENTA is $13.68 M

What is the all time high quarterly SGA for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high quarterly SGA is $16.52 M

What is Enanta Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, ENTA quarterly SGA has changed by -$112.00 K (-0.81%)

What is Enanta Pharmaceuticals TTM SGA?

The current TTM SGA of ENTA is -$1.13 B

What is the all time high TTM SGA for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high TTM SGA is $669.01 M

What is Enanta Pharmaceuticals TTM SGA year-on-year change?

Over the past year, ENTA TTM SGA has changed by -$1.18 B (-2235.15%)